C-Aryl glucoside SGLT2 inhibitors containing a biphenyl motif as potential anti-diabetic agents
摘要:
A series of highly active C-aryl glucoside SGLT2 inhibitors containing a biphenyl motif were designed and synthesized for biological evaluation. Among the compounds tested, compound 16l demonstrated high inhibitory activity against SGLT2 (IC50 = 1.9 nM) with an excellent pharmacokinetic profile. Further study indicated that the in vivo efficacy of compound 16l was comparable to that of dapagliflozin, suggesting that further development would be worthwhile. (C) 2015 Elsevier Ltd. All rights reserved.